← SynDRA
ATUVECICLIB
SynDRA canonical compound SYN0039872 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | CCNT1 | CDK9 |
|---|
| Mechanism of action | CDK9 inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- GSK3A
- EPHA1
- SRC
- MAPK15
- MAP3K9
- LYN
- IRAK1
- GSK3B
- ABL2
- FGR
- EPHB1
- YES1
- CDK2
- CAMKK2
- CAMK2G
- CAMK2D
- CAMK2B
- CSNK1D
- MUTYH
- UNG
- TRIM24
- TDG
- AURKA
- SMUG1
- OGG1
- NTRK1
- NTHL1
- NEIL2
- MAPK1
- MBD4
- BRD4
- CDK7
- BRPF1
- KIT
- FYN
- FLT4
- CASK
- FGFR3
- ABL1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CCNA1
- CCNA2
- CCNB1
- CCNE1
- CCNE2
- CCNK
- CDK1
- CDK3
- CDK5
- CDK5R1
Cross-references
Synonyms
- BAY1143572
- BAY-1143572
- atuveciclibum
- RefChem:115544
- Atuveciclib [INN]
- UNII-63Q7F59W0V
- ATUVECICLIB [WHO-DD]
- SCHEMBL25132462
- SCHEMBL29372607
- SCHEMBL30360277
- SCHEMBL30439039
- GTPL11687
- BDBM50528818
- EX-A14315
- HY-12871B
- AKOS040732534
- MS-26404
- CS-0046049
- G16466
- AKOS040732535
- PGC94388
- NSC-786098
- NCGC00475726-02
- orb1710321
- NCGC00475726-01
- Atuveciclib (BAY-1143572)
- Atuveciclib (Racemate)
- MS-26405
- C18H18FN5O2S
- SCHEMBL29942849
- BDBM168385
- D80409
- ACWKGTGIJRCOOM-UHFFFAOYSA-N
- SCHEMBL14061694
- HY-12871A
- F840720
- T10464L
- BDBM168383
Look up ATUVECICLIB in the interactive SynDRA portal →